Literature DB >> 21947774

Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.

Suneeta Chimalapati1, Jonathan Cohen, Emilie Camberlein, Claire Durmort, Helen Baxendale, Corné de Vogel, Alex van Belkum, Jeremy S Brown.   

Abstract

Avirulent strains of a bacterial pathogen could be useful tools for investigating immunological responses to infection and potentially effective vaccines. We have therefore constructed an auxotrophic TIGR4 Δpab strain of Streptococcus pneumoniae by deleting the pabB gene Sp_0665. The TIGR4 Δpab strain grew well in complete medium but was unable to grow in serum unless it was supplemented with para-aminobenzoic acid (PABA). The TIGR4 Δpab strain was markedly attenuated in virulence in mouse models of S. pneumoniae nasopharyngeal colonization, pneumonia, and sepsis. Supplementing mouse drinking water with PABA largely restored the virulence of TIGR4 Δpab. An additional Δpab strain constructed in the D39 capsular serotype 2 background was also avirulent in a sepsis model. Systemic inoculation of mice with TIGR4 Δpab induced antibody responses to S. pneumoniae protein antigens, including PpmA, PsaA, pneumolysin, and CbpD, but not capsular polysaccharide. Flow cytometry demonstrated that IgG in sera from TIGR4 Δpab-vaccinated mice bound to the surface of TIGR4 and D39 bacteria but not to a capsular serotype 3 strain, strain 0100993. Mice vaccinated with the TIGR4 Δpab or D39 Δpab strain by intraperitoneal inoculation were protected from developing septicemia when challenged with the homologous S. pneumoniae strain. Vaccination with the TIGR4 Δpab strain provided only weak or no protection against heterologous challenge with the D39 or 0100993 strain but did strongly protect against a TIGR4 capsular-switch strain expressing a serotype 2 capsule. The failure of cross-protection after systemic vaccination with Δpab bacteria suggests that parenteral administration of a live attenuated vaccine is not an attractive approach for preventing S. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947774      PMCID: PMC3232651          DOI: 10.1128/IAI.05923-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity.

Authors:  J S Brown; A Aufauvre-Brown; J Brown; J M Jennings; H Arst; D W Holden
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  p-Aminobenzoate synthesis in Escherichia coli: purification and characterization of PabB as aminodeoxychorismate synthase and enzyme X as aminodeoxychorismate lyase.

Authors:  Q Z Ye; J Liu; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4.

Authors:  Krzysztof Trzcinski; Claudette M Thompson; Marc Lipsitch
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

4.  Functional analysis of the fic gene involved in regulation of cell division.

Authors:  T Komano; R Utsumi; M Kawamukai
Journal:  Res Microbiol       Date:  1991 Feb-Apr       Impact factor: 3.992

Review 5.  Auxotrophic Salmonella typhi as live vaccine.

Authors:  B A Stocker
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

6.  The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae.

Authors:  Judy K Morona; David C Miller; Renato Morona; James C Paton
Journal:  J Infect Dis       Date:  2004-04-27       Impact factor: 5.226

Review 7.  Annotating the Plasmodium genome and the enigma of the shikimate pathway.

Authors:  Glenn A McConkey; John W Pinney; David R Westhead; Kirsten Plueckhahn; Teresa B Fitzpatrick; Peter Macheroux; Barbara Kappes
Journal:  Trends Parasitol       Date:  2004-02

8.  Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model.

Authors:  J P Long; H H Tong; T F DeMaria
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  para-aminobenzoate synthesis from chorismate occurs in two steps.

Authors:  B P Nichols; A M Seibold; S Z Doktor
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

10.  Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins.

Authors:  S Shoma; N J Verkaik; C P de Vogel; P W M Hermans; S van Selm; T J Mitchell; M van Roosmalen; S Hossain; M Rahman; H Ph Endtz; W J B van Wamel; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-18       Impact factor: 3.267

View more
  21 in total

1.  Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection.

Authors:  Xiuyu Xu; Hong Wang; Yusi Liu; Yiping Wang; Lingbing Zeng; Kaifeng Wu; Jianmin Wang; Feng Ma; Wenchun Xu; Yibing Yin; Xuemei Zhang
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

2.  Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry.

Authors:  Kathrin Moor; Jehane Fadlallah; Albulena Toska; Delphine Sterlin; Maria L Balmer; Andrew J Macpherson; Guy Gorochov; Martin Larsen; Emma Slack
Journal:  Nat Protoc       Date:  2016-07-28       Impact factor: 13.491

3.  Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.

Authors:  Sudhanshu Shekhar; Rabia Khan; Karl Schenck; Fernanda Cristina Petersen
Journal:  Appl Environ Microbiol       Date:  2019-03-06       Impact factor: 4.792

4.  Cross-protective immunity against heterologous Streptococcus pneumoniae.

Authors:  Leen Moens; Greet Wuyts; Jan Verhaegen; Xavier Bossuyt
Journal:  Infect Immun       Date:  2012-05       Impact factor: 3.441

5.  Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Authors:  Emilie Camberlein; Jonathan M Cohen; Ricardo José; Catherine J Hyams; Robin Callard; Suneeta Chimalapati; Jose Yuste; Lindsey A Edwards; Helina Marshall; Nico van Rooijen; Mahdad Noursadeghi; Jeremy S Brown
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

6.  Protective role of the capsule and impact of serotype 4 switching on Streptococcus mitis.

Authors:  Håkon V Rukke; Raja Sab Kalluru; Urska Repnik; Alice Gerlini; Ricardo J José; Jimstan Periselneris; Helina Marshall; Gareth Griffiths; Marco Rinaldo Oggioni; Jeremy S Brown; Fernanda C Petersen
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

7.  A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.

Authors:  Jason W Rosch; Amy R Iverson; Jessica Humann; Beth Mann; Geli Gao; Peter Vogel; Michael Mina; Kyle A Murrah; Antonia C Perez; W Edward Swords; Elaine I Tuomanen; Jonathan A McCullers
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

8.  Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.

Authors:  Sneha Saxena; Naeem Khan; Ruchika Dehinwal; Ajay Kumar; Devinder Sehgal
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

9.  Effects of deletion of the Streptococcus pneumoniae lipoprotein diacylglyceryl transferase gene lgt on ABC transporter function and on growth in vivo.

Authors:  Suneeta Chimalapati; Jonathan M Cohen; Emilie Camberlein; Nathanael MacDonald; Claire Durmort; Thierry Vernet; Peter W M Hermans; Timothy Mitchell; Jeremy S Brown
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation.

Authors:  Jonathan M Cohen; Suneeta Chimalapati; Corné de Vogel; Alex van Belkum; Helen E Baxendale; Jeremy S Brown
Journal:  Vaccine       Date:  2012-05-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.